Report Summary
The global Poliovirus Vaccine market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Poliovirus Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Poliovirus Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Poliovirus Vaccine in these regions.
This research report categorizes the global Poliovirus Vaccine market by top players/brands, region, type and end user. This report also studies the global Poliovirus Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market size by Product
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Market size by End User
Public
Private
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Poliovirus Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Poliovirus Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Poliovirus Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Poliovirus Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Poliovirus Vaccine are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Poliovirus Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Poliovirus Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Poliovirus Vaccine Market Size Growth Rate by Product
1.4.2 Inactivated Polio Vaccine (IPV)
1.4.3 Oral Polio Vaccine (OPV)
1.5 Market by End User
1.5.1 Global Poliovirus Vaccine Market Size Growth Rate by End User
1.5.2 Public
1.5.3 Private
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Poliovirus Vaccine Market Size
2.1.1 Global Poliovirus Vaccine Revenue 2017-2027
2.1.2 Global Poliovirus Vaccine Sales 2017-2027
2.2 Poliovirus Vaccine Growth Rate by Regions
2.2.1 Global Poliovirus Vaccine Sales by Regions
2.2.2 Global Poliovirus Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Poliovirus Vaccine Sales by Manufacturers
3.1.1 Poliovirus Vaccine Sales by Manufacturers
3.1.2 Poliovirus Vaccine Sales Market Share by Manufacturers
3.1.3 Global Poliovirus Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Poliovirus Vaccine Revenue by Manufacturers
3.2.1 Poliovirus Vaccine Revenue by Manufacturers (2017-2020)
3.2.2 Poliovirus Vaccine Revenue Share by Manufacturers (2017-2020)
3.3 Poliovirus Vaccine Price by Manufacturers
3.4 Poliovirus Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Poliovirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Poliovirus Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Poliovirus Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Poliovirus Vaccine Sales by Product
4.2 Global Poliovirus Vaccine Revenue by Product
4.3 Poliovirus Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Poliovirus Vaccine Breakdown Data by End User
6 North America
6.1 North America Poliovirus Vaccine by Countries
6.1.1 North America Poliovirus Vaccine Sales by Countries
6.1.2 North America Poliovirus Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Poliovirus Vaccine by Product
6.3 North America Poliovirus Vaccine by End User
7 Europe
7.1 Europe Poliovirus Vaccine by Countries
7.1.1 Europe Poliovirus Vaccine Sales by Countries
7.1.2 Europe Poliovirus Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Poliovirus Vaccine by Product
7.3 Europe Poliovirus Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Poliovirus Vaccine by Countries
8.1.1 Asia Pacific Poliovirus Vaccine Sales by Countries
8.1.2 Asia Pacific Poliovirus Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Poliovirus Vaccine by Product
8.3 Asia Pacific Poliovirus Vaccine by End User
9 Central & South America
9.1 Central & South America Poliovirus Vaccine by Countries
9.1.1 Central & South America Poliovirus Vaccine Sales by Countries
9.1.2 Central & South America Poliovirus Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Poliovirus Vaccine by Product
9.3 Central & South America Poliovirus Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Poliovirus Vaccine by Countries
10.1.1 Middle East and Africa Poliovirus Vaccine Sales by Countries
10.1.2 Middle East and Africa Poliovirus Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Poliovirus Vaccine by Product
10.3 Middle East and Africa Poliovirus Vaccine by End User
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Company Business Overview
11.1.3 Sanofi Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Sanofi Poliovirus Vaccine Products Offered
11.1.5 Sanofi Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Business Overview
11.2.3 GSK Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.2.4 GSK Poliovirus Vaccine Products Offered
11.2.5 GSK Recent Development
11.3 Bibcol
11.3.1 Bibcol Company Details
11.3.2 Company Business Overview
11.3.3 Bibcol Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Bibcol Poliovirus Vaccine Products Offered
11.3.5 Bibcol Recent Development
11.4 Serum Institute
11.4.1 Serum Institute Company Details
11.4.2 Company Business Overview
11.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Serum Institute Poliovirus Vaccine Products Offered
11.4.5 Serum Institute Recent Development
11.5 Tiantan Biological
11.5.1 Tiantan Biological Company Details
11.5.2 Company Business Overview
11.5.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Tiantan Biological Poliovirus Vaccine Products Offered
11.5.5 Tiantan Biological Recent Development
11.6 IMBCA
11.6.1 IMBCA Company Details
11.6.2 Company Business Overview
11.6.3 IMBCA Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.6.4 IMBCA Poliovirus Vaccine Products Offered
11.6.5 IMBCA Recent Development
11.7 Panacea Biotec Ltd
11.7.1 Panacea Biotec Ltd Company Details
11.7.2 Company Business Overview
11.7.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Panacea Biotec Ltd Poliovirus Vaccine Products Offered
11.7.5 Panacea Biotec Ltd Recent Development
11.8 Bio-Med
11.8.1 Bio-Med Company Details
11.8.2 Company Business Overview
11.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Bio-Med Poliovirus Vaccine Products Offered
11.8.5 Bio-Med Recent Development
11.9 Halfkin Bio-Pharmaceuticals
11.9.1 Halfkin Bio-Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Products Offered
11.9.5 Halfkin Bio-Pharmaceuticals Recent Development
12 Future Forecast
12.1 Poliovirus Vaccine Market Forecast by Regions
12.1.1 Global Poliovirus Vaccine Sales Forecast by Regions 2021-2027
12.1.2 Global Poliovirus Vaccine Revenue Forecast by Regions 2021-2027
12.2 Poliovirus Vaccine Market Forecast by Product
12.2.1 Global Poliovirus Vaccine Sales Forecast by Product 2021-2027
12.2.2 Global Poliovirus Vaccine Revenue Forecast by Product 2021-2027
12.3 Poliovirus Vaccine Market Forecast by End User
12.4 North America Poliovirus Vaccine Forecast
12.5 Europe Poliovirus Vaccine Forecast
12.6 Asia Pacific Poliovirus Vaccine Forecast
12.7 Central & South America Poliovirus Vaccine Forecast
12.8 Middle East and Africa Poliovirus Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Poliovirus Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
